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Abstract
We present a case of a papillary tumour at the cerebellopontine angle in a 41-year-old man. He 
presented with left-sided facial and ear pain associated with dizziness, nystagmus and hearing 
loss. CT scan of the temporal bone showed a destructive tumour at the left cerebellopontine angle. 
Surgical excision was performed and the diagnosis of the endolymphatic sac tumour was made. 
Endolymphatic tumour is a low grade adenocarcinoma that originates from the endolymphatic 
sac. The defi nitive diagnosis requires a combination of clinical features, radiological fi nding and 
pathological correlation. 
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CASE REPORT
INTRODUCTION
Endolymphatic sac tumour (ELST) is a slow 
growing tumour which widely invades the 
petrous bone. It is extremely rare in the general 
population and has an association with von 
Hippel-Lindau disease. Because of the rarity of 
this tumour, this lesion may be overlooked by 
clinicians.  We present a case of endolymphatic 
sac tumour in a 41-year-old man who was 
clinically and radiologically diagnosed as glomus 
tumour and review the available literature on its 
clinicopathological features. 
CASE REPORT
A 41-year-old man presented with left-sided 
facial paralysis and intermittent left ear discharge 
for two years. He also complained of dizziness, 
left ear hearing loss and left sided headache. 
Physical examination revealed House Brackmann 
Grade VI left lower motor neuron facial nerve 
palsy. Otological examination showed left 
pulsatile healed tympanic membrane without any 
discharge. Meanwhile, pure tone audiography 
confi rmed profound sensorineural hearing loss 
of his left ear. Other ENT examination revealed 
insignifi cant fi ndings.
 High Resolution Computed tomography 
(HRCT) scan was performed and showed an 
enhancing lesion at the left cerebellopontine angle 
causing destructive changes of the mastoid and 
petrous bone with dehiscent of the left carotid 
canal (Fig.  1). The radiological diagnosis at 
that time was glomus jugulare paraganglioma. 
Magnetic resonance imaging (MRI) was 
ordered to delineate the soft tissue mass clearer. 
He then underwent tumour excision via 
translabyrinthine and transsigmoid approaches 
by the combined team of neurosurgeon and ENT 
surgeon. Intraoperatively, the tumour was at left 
cerebellopontine angle measuring approximately 
3x6cm. The tumour eroded the posterior wall of 
the middle ear and involved the sigmoid sinus. 
Total excision of the tumour was attended. 
He was complicated by cerebrospinal fl uid 
leak postoperatively. Fortunately, the leak was 
resolved day fi ve postoperatively with insertion 
of the lumbar drain. He was then discharged 
uneventfully.
Pathology
Histopathological examination showed 
endolymphatic sac tumour. On hematoxylin 
and eosin staining, the tumour showed papillary 
projections with thin fi brovascular core. The 
papillae were lined by a single layer of low 
columnar and cuboidal epithelium. (Fig.  2a) 
Areas of glandular structures with similar 
epithelial linings and eosinophilic secretion are 
noted. (Fig.  2b) The neoplastic cells showed 
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monomorphic nuclei with no mitotic fi gures or 
atypia seen. The adjacent stroma shows foci of 
foamy macrophages, cholesterol granuloma and 
rich proliferation of small capillaries. 
 Immunohistochemical study was performed 
and the tumour showed positivity towards 
cytokeratin, epithelial membrane antigen (EMA) 
and focal positivity towards glial fi brillary acidic 
protein (GFAP). Stains for thyroid transcription 
factor- 1 (TTF-1), smooth muscle actin and 
prostate specifi c antigen were negative. 
 He was followed up by both neurosurgical 
and ENT team. Repeated MRI of the brain 
two months postoperatively revealed residual 
tumour and he was referred to oncologist for 
radiotherapy. He underwent 30 fractions of 
external beam radiotherapy. His latest CT scan 
in January 2011 showed no residual tumour seen. 
Currently, he is still under ENT clinic follow-
up.
DISCUSSION
Neoplasm arising from the endolymphatic sac 
was fi rst described by Hassard.1 Subsequently, 
the term low grade adenocarcinoma of 
endolymphatic sac origin was coined by 
Heffner who found similarities in the anatomical 
FIG. 1 Axial plain CT scan in bone setting at the level of mastoids showing soft tissue lesion occupying the left 
mastoid air cells with loss of the expected bony trabeculae within (*). The soft tissue density within the 
mastoids has eroded the medial wall of the temporal bone extending into the external and middle ear 
canal (curved arrow).
Fig. 2a Endolymphatic sac tumour showing papillary structures lined by a single layer of cuboidal epithelium. 
Fig. 2b Endolymphatic sac tumour showing glandular structures fi lled with eosinophilic material.




location and histological features of the normal 
endolymphatic sac to this tumour.2
 ELST is reported to be more common in 
females with a mean presenting age of 45 
years. Sensorineural hearing loss, tinnitus and 
vertigo are the typical presenting symptoms 
in patients with ELST as seen in our patient. 
Cranial nerve paralysis including facial nerve 
palsy and cerebellar disorders develops as the 
tumour extends into the jugular foramen and 
cerebellopontine angle.3 This neoplasm behaves 
as a slow growing tumour which is locally 
invasive and exhibits bone destruction. Earlier 
reported cases of ELST showed no metastasis 
but recently ELST metastasis to the spine has 
been observed.4
 The majority of ELST are sporadic while 
around 15% of patients have an autosomal 
dominant inherited disorder, von Hippel-Lindau 
disease. Patients with von Hippel-Lindau disease 
have a germline mutation in the VHL tumour 
suppressor gene that is responsible for their 
genetic susceptibility to various neoplasms. 
Apart from ELST, von Hippel-Lindau disease is 
associated with haemangioblastoma of the central 
nervous system, choroid plexus papilloma, 
renal cell carcinoma, phaeochromocytoma and 
papillary cystadenoma of the epidydimis.5 
 CT scan typically shows a retrolabyrinthine 
mass which displays temporal bone erosion as 
the tumour expands. Radiological differential 
diagnosis includes paraganglioma, endolymphatic 
sac tumour, metastasis from occult primary 
tumours, chondrosarcoma and cholesterol 
granuloma.6
 Grossly, these tumours appear reddish or 
bluish, hypervascular and are soft in consistency. 
Under the microscope, two main growth patterns 
may be observed as in our patient. The fi rst 
growth pattern shows colloid fi lled cysts lined 
by a single layered low cuboidal epithelium 
with relatively minimal stroma. Occasionally, 
this thyroid-like area may be the predominant 
histological feature in the biopsy. The second 
growth pattern is characterized by abundant 
papillary and solid architecture with vascularized 
stroma. The stromal component of ELST may 
show areas of haemorrhage with foamy, giant 
cell or hemosiderin-laden macrophages.7
 Defi nitive diagnosis of ELST may be diffi cult 
to reach due to the rarity of this tumour and 
its various architectural presentations. Possible 
differential diagnosis includes metastatic 
follicular thyroid carcinoma, metastatic renal cell 
carcinoma, metastatic prostate adenocarcinoma, 
paraganglioma and choroid plexus papilloma. 
Thus the use of immunohistochemical studies 
is essential. ELST expresses cytokeratin and 
glial fi brillary acidic protein while it is negative 
for specifi c markers for metastases including 
thyroglobulin and prostate specifi c antigen.7
 Surgery remains the treatment of choice for 
ELST. However, total excision of the tumour is 
often not possible due to its aggressive growth 
pattern. Recurrences could occur years after the 
primary surgery.2
ACKNOWLEDGEMENT
The authors would like to acknowledge Datin Dr 
Fauziah Kassim, Prof Dr Prepageran Narayanan, 
Dr Jacqueline Wong Oy Leng and Dr Tan Tee 
Yong in the preparation of the manuscript.
REFERENCES
 1. Hassard AD, Boudreau SF, Cron CC. Adenoma 
of the endolymphatic sac. J Otolaryngol 
1984;13(4):213-6.
 2.  Heffner DK. Low-grade adenocarcinoma of probable 
endolymphatic sac origin A clinicopathologic study 
of 20 cases. Cancer 1989;64(11):2292-302.
 3.  Richards PS, Clifton AG. Endolymphatic sac 
tumours. J Laryngol Otol 2003;117(8):666-9.
 4.  Bambakidis NC, Rodrigue T, Megerian CA, 
Ratcheson RA. Endolymphatic sac tumor metastatic 
to the spine. Case report. J Neurosurg Spine 
2005;3(1):68-70.
 5.  Gaffey MJ, Mills SE, Boyd JC. Aggressive 
papillary tumor of middle ear/temporal bone and 
adnexal papillary cystadenoma. Manifestations 
of von Hippel-Lindau disease. Am J Surg Pathol 
1994;18(12):1254-60.
 6.  Banerjee A, Whyte A, O’Sullivan P, Atlas 
MD. Endolymphatic sac tumor. Otol Neurotol 
2005;26(4):819-20.
 7.  Kempermann G, Neumann HP, Volk B. Endolymphatic 
sac tumours. Histopathology 1998;33(1):2-10.
 
